913 related articles for article (PubMed ID: 31754391)
1. Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis.
He L; Zhu W; Chen Q; Yuan Y; Wang Y; Wang J; Wu X
Theranostics; 2019; 9(26):8206-8220. PubMed ID: 31754391
[No Abstract] [Full Text] [Related]
2. Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.
Zhu X; Shen H; Yin X; Yang M; Wei H; Chen Q; Feng F; Liu Y; Xu W; Li Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):81. PubMed ID: 30770776
[TBL] [Abstract][Full Text] [Related]
3. Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.
Kanlikilicer P; Bayraktar R; Denizli M; Rashed MH; Ivan C; Aslan B; Mitra R; Karagoz K; Bayraktar E; Zhang X; Rodriguez-Aguayo C; El-Arabey AA; Kahraman N; Baydogan S; Ozkayar O; Gatza ML; Ozpolat B; Calin GA; Sood AK; Lopez-Berestein G
EBioMedicine; 2018 Dec; 38():100-112. PubMed ID: 30487062
[TBL] [Abstract][Full Text] [Related]
4. Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma.
Lu J; Liu QH; Wang F; Tan JJ; Deng YQ; Peng XH; Liu X; Zhang B; Xu X; Li XP
J Exp Clin Cancer Res; 2018 Jul; 37(1):147. PubMed ID: 30001734
[TBL] [Abstract][Full Text] [Related]
5. Exosomal circNFIX promotes angiogenesis in ovarian cancer via miR-518a-3p/TRIM44 axis.
Ye H; Wang RY; Yu XZ; Wu YK; Yang BW; Ao MY; Xi MR; Hou MM
Kaohsiung J Med Sci; 2023 Jan; 39(1):26-39. PubMed ID: 36448712
[TBL] [Abstract][Full Text] [Related]
6. Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma.
Wu XG; Zhou CF; Zhang YM; Yan RM; Wei WF; Chen XJ; Yi HY; Liang LJ; Fan LS; Liang L; Wu S; Wang W
Angiogenesis; 2019 Aug; 22(3):397-410. PubMed ID: 30993566
[TBL] [Abstract][Full Text] [Related]
7. Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma.
Wang ZF; Liao F; Wu H; Dai J
J Exp Clin Cancer Res; 2019 May; 38(1):201. PubMed ID: 31101062
[TBL] [Abstract][Full Text] [Related]
8. Lithium-containing biomaterials stimulate bone marrow stromal cell-derived exosomal miR-130a secretion to promote angiogenesis.
Liu L; Liu Y; Feng C; Chang J; Fu R; Wu T; Yu F; Wang X; Xia L; Wu C; Fang B
Biomaterials; 2019 Feb; 192():523-536. PubMed ID: 30529871
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
10. Metastasis-associated miR-23a from nasopharyngeal carcinoma-derived exosomes mediates angiogenesis by repressing a novel target gene TSGA10.
Bao L; You B; Shi S; Shan Y; Zhang Q; Yue H; Zhang J; Zhang W; Shi Y; Liu Y; Wang X; Liu D; You Y
Oncogene; 2018 May; 37(21):2873-2889. PubMed ID: 29520105
[TBL] [Abstract][Full Text] [Related]
11. Exosomal release of microRNA-454 by breast cancer cells sustains biological properties of cancer stem cells via the PRRT2/Wnt axis in ovarian cancer.
Wang L; He M; Fu L; Jin Y
Life Sci; 2020 Sep; 257():118024. PubMed ID: 32598931
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression.
Liu H; Liu Y; Sun P; Leng K; Xu Y; Mei L; Han P; Zhang B; Yao K; Li C; Bai J; Cui B
Clin Sci (Lond); 2020 Feb; 134(4):419-434. PubMed ID: 32065214
[TBL] [Abstract][Full Text] [Related]
13. Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway.
Zhou X; Yan T; Huang C; Xu Z; Wang L; Jiang E; Wang H; Chen Y; Liu K; Shao Z; Shang Z
J Exp Clin Cancer Res; 2018 Oct; 37(1):242. PubMed ID: 30285793
[TBL] [Abstract][Full Text] [Related]
14. Potential of peptide-engineered exosomes with overexpressed miR-92b-3p in anti-angiogenic therapy of ovarian cancer.
Wang J; Wang C; Li Y; Li M; Zhu T; Shen Z; Wang H; Lv W; Wang X; Cheng X; Xie X
Clin Transl Med; 2021 May; 11(5):e425. PubMed ID: 34047469
[TBL] [Abstract][Full Text] [Related]
15. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
[TBL] [Abstract][Full Text] [Related]
16. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
Su YY; Sun L; Guo ZR; Li JC; Bai TT; Cai XX; Li WH; Zhu YF
J Ovarian Res; 2019 Jan; 12(1):6. PubMed ID: 30670062
[TBL] [Abstract][Full Text] [Related]
17. Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer.
Zhang W; Su X; Li S; Liu Z; Wang Q; Zeng H
Cancer Biomark; 2020; 27(4):485-491. PubMed ID: 32065786
[TBL] [Abstract][Full Text] [Related]
18. Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis.
Zeng Z; Li Y; Pan Y; Lan X; Song F; Sun J; Zhou K; Liu X; Ren X; Wang F; Hu J; Zhu X; Yang W; Liao W; Li G; Ding Y; Liang L
Nat Commun; 2018 Dec; 9(1):5395. PubMed ID: 30568162
[TBL] [Abstract][Full Text] [Related]
19. Exosomal circTUBGCP4 promotes vascular endothelial cell tipping and colorectal cancer metastasis by activating Akt signaling pathway.
Chen C; Liu Y; Liu L; Si C; Xu Y; Wu X; Wang C; Sun Z; Kang Q
J Exp Clin Cancer Res; 2023 Feb; 42(1):46. PubMed ID: 36793126
[TBL] [Abstract][Full Text] [Related]
20. Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1.
Hsu YL; Hung JY; Chang WA; Lin YS; Pan YC; Tsai PH; Wu CY; Kuo PL
Oncogene; 2017 Aug; 36(34):4929-4942. PubMed ID: 28436951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
